FMP

FMP

Enter

SYK - Stryker Corporation

photo-url-https://images.financialmodelingprep.com/symbol/SYK.png

Stryker Corporation

SYK

NYSE

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

339.59 USD

-6.91 (-2.03%)

SYK Financial Statements

Year

2024

2023

2022

2021

Total Revenue

22.59B

20.5B

18.45B

17.11B

Cost of Revenue

8.15B

7.4B

6.87B

6.14B

Gross Profit

14.44B

13.1B

11.58B

10.97B

Operating Expenses

10.75B

9.21B

8.54B

8.28B

Research and Development

1.47B

1.39B

1.45B

1.24B

Selling, General & Administrative Expenses

7.68B

6.92B

6.46B

6.43B

Selling & Marketing Expenses

0

0

0

0

General & Administrative Expenses

0

0

0

0

Other Expenses

1.6B

901M

627M

619M

Operating Income

3.69B

3.89B

2.84B

2.58B

Total Other Income/Expenses Net

-197M

-215M

-158M

-303M

Income Before Tax

3.49B

3.67B

2.68B

2.28B

Income Tax

499M

508M

325M

287M

Net Income

2.99B

3.17B

2.36B

1.99B

Basic EPS

7.86

8.34

6.23

5.29

EPS Diluted

7.76

8.25

6.17

5.22

Basic Average Shares

381M

379.6M

378.2M

377M

Diluted Average Shares

385.6M

383.7M

382.2M

382.3M

EBITDA

5.72B

4.93B

4.54B

4.65B

Retained Earning Schedule

Year

2024

2023

2022

2021

Retained Earnings (Previous Year)

16.77B

14.77B

13.48B

12.46B

Net Income

2.99B

3.17B

2.36B

1.99B

Stock Repurchases

0

-155M

-122M

-114M

Dividend Paid

-1.22B

-1.14B

-1.05B

-950M

Retained Earnings

18.53B

16.77B

14.77B

13.48B

Other Distributions

538M

712M

112M

-46M

PPE Schedule

Year

2024

2023

2022

2021

Gross PPE

3.45B

3.21B

2.97B

2.83B

Annual Depreciation

1.05B

1.03B

998M

990M

Capital Expenditure

-755M

-575M

-588M

-525M

Net PPE

3.15B

2.76B

2.56B

2.37B

Intangible and Goodwill Schedule

Year

2024

2023

2022

2021

Acquisitions and Adjustments

612M

363M

1.96B

140M

Goodwill (Previous Year)

15.24B

14.88B

12.92B

12.78B

Goodwill

15.86B

15.24B

14.88B

12.92B

All figures are in USD.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2025 © Financial Modeling Prep